Brief: Theranexus Q4 Free Cash Flow Stands At 9.5 Million Euros
Jan 27 (Reuters) - Theranexus SA ALTHX.PA :
* FREE CASH FLOW STOOD AT EUR 9,452 THOUSAND AS OF DEC 31,
2019
COMPARED TO EUR 9,542 THOUSAND AS OF SEPT 30, 2019
Source text : https://bit.ly/36wj6UT
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease